Navigation Links
Genta Completes Appeal of FDA Decision for Genasense(R) in CLL
Date:10/25/2007

- the Company's ability to obtain necessary regulatory approval for

Genasense(R) from the U.S. Food and Drug Administration ("FDA") or

European Medicines Agency ("EMEA");

- the safety and efficacy of the Company's products or product candidates;

- the Company's assessment of its clinical trials;

- the commencement and completion of clinical trials;

- the Company's ability to develop, manufacture, license and sell its

products or product candidates;

- the Company's ability to enter into and successfully execute license and

collaborative agreements, if any;

- the adequacy of the Company's capital resources and cash flow

projections, and the Company's ability to obtain sufficient financing to

maintain the Company's planned operations;

- the adequacy of the Company's patents and proprietary rights;

- the impact of litigation that has been brought against the Company and

its officers and directors and any proposed settlement of such

litigation; and

- the other risks described under Certain Risks and Uncertainties Related

to the Company's Business, as contained in the Company's Annual Report

on Form 10-K and Quarterly Report on Form 10-Q.

The Company does not undertake to update any forward-looking statements. There are a number of factors that could cause actual results and developments to differ materially. For a discussion of those risks and uncertainties, please see the Company's Annual Report on Form 10-K for 2006 and its most recent quarterly report on Form 10-Q.

CONTACT:

Brian Korb

The Trout Group

908-286-3980

info@genta.com


'/>"/>
SOURCE Genta Incorporated
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Sonic Foundry completes $11.25M stock offer
2. Orion Energy completes $5M capital round
3. RedPrairie completes MARC acquisition
4. Metavante completes purchase of check processing firm
5. GE completes $1.2 billion acquisition
6. M & Is Metavante completes Brasfield Corp. acquisition
7. Metavante completes GHR Systems acquisition
8. Metavante completes TREEV acquisition
9. Johnson Controls completes sale of French unit
10. OpGen completes $5 million investment round
11. UW Hospital completes deployment of error-reducing technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Poway, CA (PRWEB) July 10, 2014 Robert ... Regenerative Veterinary Medicine company, is proud to announce the relaunch ... Pets, launching with a new series called “ What are ... to give an honest and straightforward foundation in the basics ... an educated decision on the right type of treatment when ...
(Date:7/10/2014)... CROWN POINT, Ind. , July 10, ... recently expanded its use of capnography for ... a growing group of healthcare leaders in ... Capnography measures how effectively patients are breathing ... respiratory depression occurs. By measuring the amount ...
(Date:7/10/2014)... Research and Markets ( http://www.researchandmarkets.com/research/s3bqj2/photonic ) ... Photonic Integrated Circuit (Monolithic Integration, Hybrid Integration, Module ... to their offering. ... integration traces its roots in the latter half ... integration went unexplored and unfulfilled for several decades ...
(Date:7/10/2014)... Using microscopic polymer light resonators that expand in ... Quantum Photonics Laboratory have developed new optical sensors ... Optical sensors are ideal for detecting trace gas ... lightweight nature, and immunity to electromagnetic interference. , ... before, the MIT team conceived an extremely sensitive, ...
Breaking Biology Technology:Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 2Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 3Franciscan St. Anthony Health-Crown Point Underscores Patient Safety Commitment Through Expanded Use of Capnography 2International Photonic Integrated Circuit (Monolithic Integration, Hybrid Integration, Module Integration) Market - Forecasts to 2019 2Swell new sensors 2
... ISELIN, N.J., July 30 SyntheMed, Inc. (OTC ... development and commercialization of anti-adhesion products, announced today that ... its bioresorbable reverse thermal gelation polymer technology. This ... this novel technology and pertains to the application of ...
... , MONMOUTH JUNCTION, N.J., July ... into a cooperative research and development agreement with the National ... National Institutes of Health (NIH), to study ARIKACE(TM) (liposomal amikacin ... , , Transave and NIAID will collaborate ...
... , CHADDS FORD, Pa., July 30 Endo Pharmaceuticals ... quarter of 2009, including a full quarter of results of Indevus Pharmaceuticals, ... Total revenues during the second quarter of 2009 increased 22 percent ... 2008. Net income for the three months ended June 30, 2009, ...
Cached Biology Technology:SyntheMed Receives US Patent on Novel Polymer Technology 2Transave Enters Into Cooperative Research Agreement With NIH To Study ARIKACE(TM) In Nontuberculous Mycobacteria 2Transave Enters Into Cooperative Research Agreement With NIH To Study ARIKACE(TM) In Nontuberculous Mycobacteria 3Transave Enters Into Cooperative Research Agreement With NIH To Study ARIKACE(TM) In Nontuberculous Mycobacteria 4Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results 2Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results 3Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results 4Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results 5Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results 6Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results 7Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results 8Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results 9Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results 10Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results 11Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results 12Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results 13Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results 14Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results 15Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results 16
(Date:7/11/2014)... July 10, 2014---A team of researchers from The Chinese ... identified a gene of wild soybean linked to salt ... grow in saline soil. This study published online in ... unveil novel genomic information for crop improvement. , Soybean ... domestication and human selection, cultivated soybeans have less genetic ...
(Date:7/11/2014)... July 11, 2014 Researchers have pioneered ... images. The new technology, called Virtual Finger, allows ... structures like neurons and synapses using the flat ... technology makes 3D imaging studies orders of magnitude ... an unprecedented level across many areas of experimental ...
(Date:7/11/2014)... receptor type 1 can inhibit voltage-gated calcium ... neurotransmitter release. However, some scholars demonstrated that ... Ca2+ influx and increase neurotransmitter release. Dr. ... Affiliated to Tongji Medical College, Huazhong University ... cell voltage-clamp and calcium imaging in cultured ...
Breaking Biology News(10 mins):BGI reports a novel gene for salt tolerance found in wild soybean 2Virtual finger enables scientists to navigate and analyze complex 3D images 2
... MURCIA, SPAINSalt can have drastic effects on the ... that salinity renders an about one-third of the world,s ... salinity can cause ion toxicity, osmotic stress, mineral deficiencies, ... stress can even cause plants to adjust their water ...
... of modern humans like more than 50,000 years ago? ... Stone Age engravings are the subjects of a good deal ... journal Science , an international team of researchers report ... could place the use of herbal medicines much earlier than ...
... growing in popularity as more growers turn to strip-till. However, ... worth. A new University of Illinois study revealed ... soybean. However, the results showed no difference in yield between ... corn, not soybean," said Fabian Fernandez, U of I assistant ...
Cached Biology News:Salt-tolerant crops show higher capacity for carbon fixation 2Earliest known bug-repellant plant bedding found at South African rock shelter 2Earliest known bug-repellant plant bedding found at South African rock shelter 3Earliest known bug-repellant plant bedding found at South African rock shelter 4Strip-till improves nutrient uptake and yield 2
SHEEP ANTI BOVINE LACTOPEROXIDASE...
... in utility and flexibility press-to-seal silicone isolators ... of the researcher. They are available either ... sheet material that can be easily trimmed ... autoclavable and non-cytotoxic and can be used ...
Request Info...
... Provides up to 30 minutes of walkaway time. Automatic Calibration. Five minute cooldown ... port. ... ... ...
Biology Products: